Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Laura Orsolini, Simone Pompili & Umberto Volpe. (2020) The ‘collateral side’ of mood stabilizers: safety and evidence-based strategies for managing side effects. Expert Opinion on Drug Safety 19:11, pages 1461-1495.
Read now
Read now
Seetal Dodd, Gin S. Malhi, John Tiller, Isaac Schweitzer, Ian Hickie, Jon Paul Khoo, Darryl L. Bassett, Bill Lyndon, Philip B. Mitchell, Gordon Parker, Paul B. Fitzgerald, Marc Udina, Ajeet Singh, Steven Moylan, Francesco Giorlando, Carolyn Doughty, Christopher G. Davey, Michael Theodoros & Michael Berk. (2011) A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Australian and New Zealand Journal of Psychiatry 45:9, pages 712-725.
Read now
Read now
Carmina G Bernardo, Vivek Singh & Peter M Thompson. (2008) Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders. Expert Opinion on Drug Safety 7:4, pages 435-445.
Read now
Read now
Articles from other publishers (14)
David C. Steffens & Kristina F. ZdanysBenoit Mulsant & Bruce Pollock. 2022. The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry. The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry.
Mireia Martínez Cortés & Pedro Gurillo Muñoz. 2019. Fluid and Electrolyte Disorders. Fluid and Electrolyte Disorders.
Thitiporn Supasitthumrong, Blanca M. Bolea‐Alamanac, Selim Asmer, Vincent L. Woo, Petal S. Abdool & Simon J.C. Davies. (2019) Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. British Journal of Clinical Pharmacology 85:4, pages 690-703.
Crossref
Crossref
Damien Gallagher & Nathan Herrmann. (2014) Antiepileptic Drugs for the Treatment of Agitation and Aggression in Dementia: Do They Have a Place in Therapy?. Drugs 74:15, pages 1747-1755.
Crossref
Crossref
Abhilash K. Desai, Lori Schwartz & George T. Grossberg. (2012) Behavioral Disturbance in Dementia. Current Psychiatry Reports 14:4, pages 298-309.
Crossref
Crossref
Christian R. Dolder & Kimberly L. Nealy. (2012) The Efficacy and Safety of Newer Anticonvulsants in Patients with Dementia. Drugs & Aging 29:8, pages 627-637.
Crossref
Crossref
Nagwa M. Abdel Gawad, Ghaneya S. Hassan, Hanan H. Georgey & Hesham Y. El-Zorba. (2011) Benzoxepin derivatives: design, synthesis, and pharmacological evaluation with sedative–hypnotic effect. Medicinal Chemistry Research 21:6, pages 747-759.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
255
277
.
Judith Neugroschl & Sophia Wang. (2011) Alzheimer's Disease: Diagnosis and Treatment Across the Spectrum of Disease Severity. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:4, pages 596-612.
Crossref
Crossref
Arash Mowla & Azadeh Pani. (2010) Comparison of Topiramate and Risperidone for the Treatment of Behavioral Disturbances of Patients With Alzheimer Disease. Journal of Clinical Psychopharmacology 30:1, pages 40-43.
Crossref
Crossref
Alessandro Massella, Marco Gusciglio, Giulia D'Intino, Sandra Sivilia, Luca Ferraro, Laura Calzà & Luciana Giardino. (2009) Gabapentin treatment improves motor coordination in a mice model of progressive ataxia. Brain Research 1301, pages 135-142.
Crossref
Crossref
Sarah J Mitchell, Sarah N Hilmer & Andrew J McLachlan. (2009) Clinical pharmacology of analgesics in old age and frailty. Reviews in Clinical Gerontology 19:2, pages 103-118.
Crossref
Crossref
Richard P. Shank & Bruce E. Maryanoff. (2008) Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate. CNS Neuroscience & Therapeutics 14:2, pages 120-142.
Crossref
Crossref
Yunie Kim, Kirsten M Wilkins & Rajesh R Tampi. (2008) Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia. Drugs & Aging 25:3, pages 187-196.
Crossref
Crossref